These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15845987)

  • 1. Managing chronic diseases: combination of inhaler treatment in India has shown good results.
    Koul PA
    BMJ; 2005 Apr; 330(7497):964; discussion 964-5. PubMed ID: 15845987
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?
    Tennant RC; Erin EM; Barnes PJ; Hansel TT
    Curr Opin Pharmacol; 2003 Jun; 3(3):270-6. PubMed ID: 12810191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease.
    Cramer JA; Bradley-Kennedy C; Scalera A
    Can Respir J; 2007; 14(1):25-9. PubMed ID: 17315055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients.
    Cazzola M; Noschese P; Salzillo A; De Giglio C; D'Amato G; Matera MG
    Respir Med; 2005 May; 99(5):524-8. PubMed ID: 15823447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A step forward in COPD management: reading between the lines.
    Chapman KR
    Chest; 2012 Nov; 142(5):1082-1085. PubMed ID: 23131928
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.
    Rabe KF; Timmer W; Sagkriotis A; Viel K
    Chest; 2008 Aug; 134(2):255-262. PubMed ID: 18403672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
    Tashkin DP; Littner M; Andrews CP; Tomlinson L; Rinehart M; Denis-Mize K
    Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD.
    Cazzola M; Matera MG; Di Perna E; Califano C; D'Amato M; Mazzarella G
    Respir Med; 1999 Dec; 93(12):909-11. PubMed ID: 10653054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilator efficacy of tiotropium-formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD.
    Salvi S; Brashier B; Gothi D; Karkhanis V; Madas S; Gogtay J; Joshi J
    Pulm Pharmacol Ther; 2014 Feb; 27(1):90-5. PubMed ID: 23752057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease?
    Tashkin DP
    Curr Opin Pulm Med; 2005 Mar; 11(2):121-8. PubMed ID: 15699783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease.
    Prenner BM
    Expert Opin Pharmacother; 2007 Dec; 8(17):3069-84. PubMed ID: 18001266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.
    Hanania NA; Boota A; Kerwin E; Tomlinson L; Denis-Mize K
    Drugs; 2009 Jun; 69(9):1205-16. PubMed ID: 19537837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical trough effects of triple therapy with budesonide/formoterol and tiotropium bromide on pulmonary function outcomes in COPD.
    Williamson PA; Short PM; Clearie KL; Vaidyanathan S; Fardon TC; Howaniec LJ; Lipworth BJ
    Chest; 2010 Sep; 138(3):595-604. PubMed ID: 20418370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
    Welsh EJ; Cates CJ; Poole P
    Cochrane Database Syst Rev; 2010 May; (5):CD007891. PubMed ID: 20464758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Other forms of bronchodilation].
    Izquierdo Alonso JL; Malo de Molina R
    Arch Bronconeumol; 2004 Mar; 40 Suppl 1():23-9. PubMed ID: 16137446
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.
    van Noord JA; Aumann JL; Janssens E; Smeets JJ; Verhaert J; Disse B; Mueller A; Cornelissen PJ
    Eur Respir J; 2005 Aug; 26(2):214-22. PubMed ID: 16055868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD009039. PubMed ID: 21901729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do we critically use long-acting muscarinic receptor antagonists and beta-adrenergic receptor agonists monotherapy, or these combination therapies depending on the situation in Japanese patients with COPD?
    Kawayama T; Sasaki J
    Respir Investig; 2017 Nov; 55(6):323-325. PubMed ID: 29153411
    [No Abstract]   [Full Text] [Related]  

  • 19. Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease.
    Yasui H; Inui N; Furuhashi K; Nakamura Y; Uto T; Sato J; Yasuda K; Takehara Y; Suda T; Chida K
    Pulm Pharmacol Ther; 2013 Jun; 26(3):336-41. PubMed ID: 23340058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium.
    O'Connor AB
    Ann Intern Med; 2006 Jan; 144(2):148; author reply 148-9. PubMed ID: 16418423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.